These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 22874202)
1. Knowledge-based tacrolimus therapy for kidney transplant patients. Seeling W; Plischke M; Schuh C Stud Health Technol Inform; 2012; 180():310-4. PubMed ID: 22874202 [TBL] [Abstract][Full Text] [Related]
2. Knowledge-based immunosuppressive therapy for kidney transplant patients--from theoretical model to clinical integration. Seeling W; Plischke M; de Bruin JS; Schuh C Stud Health Technol Inform; 2015; 216():1119. PubMed ID: 26262418 [TBL] [Abstract][Full Text] [Related]
3. Dosing tacrolimus based on CYP3A5 genotype: will it improve clinical outcome? van Gelder T; Hesselink DA Clin Pharmacol Ther; 2010 Jun; 87(6):640-1. PubMed ID: 20485320 [TBL] [Abstract][Full Text] [Related]
4. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients. Zhao W; Fakhoury M; Baudouin V; Maisin A; Deschênes G; Jacqz-Aigrain E Ther Drug Monit; 2011 Dec; 33(6):681-7. PubMed ID: 22011724 [TBL] [Abstract][Full Text] [Related]
5. Tacrolimus in kidney transplantation. Kliem V; Brunkhorst R Contrib Nephrol; 1998; 124():103-16; discussion 116-25. PubMed ID: 9761977 [No Abstract] [Full Text] [Related]
6. Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study. El-Dahshan KF; Bakr MA; Donia AF; Badr Ael-S; Sobh MA Am J Nephrol; 2006; 26(3):293-8. PubMed ID: 16804292 [TBL] [Abstract][Full Text] [Related]
7. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients. Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683 [TBL] [Abstract][Full Text] [Related]
8. Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation. Calia R; Lai C; Aceto P; Luciani M; Romagnoli J; Lai S; Gargiulo A; Citterio F Transplant Proc; 2011 May; 43(4):1020-3. PubMed ID: 21620041 [TBL] [Abstract][Full Text] [Related]
9. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788 [TBL] [Abstract][Full Text] [Related]
10. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen. Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042 [TBL] [Abstract][Full Text] [Related]
11. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report. Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597 [TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Staatz CE; Willis C; Taylor PJ; Tett SE Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients. Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595 [TBL] [Abstract][Full Text] [Related]
14. [The therapeutic drug monitoring network server of tacrolimus for Chinese renal transplant patients]. Deng CH; Zhang GM; Bi SS; Zhou TY; Lu W Yao Xue Xue Bao; 2011 Jul; 46(7):828-33. PubMed ID: 22010353 [TBL] [Abstract][Full Text] [Related]
15. Dried blood spot measurement of tacrolimus is promising for patient monitoring. Hoogtanders K; van der Heijden J; Christiaans M; van de Plas A; van Hooff J; Stolk L Transplantation; 2007 Jan; 83(2):237-8. PubMed ID: 17264824 [TBL] [Abstract][Full Text] [Related]
16. Tacrolimus in pediatric renal transplantation: a review. Shapiro R Pediatr Transplant; 1998 Nov; 2(4):270-6. PubMed ID: 10084728 [TBL] [Abstract][Full Text] [Related]
17. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipients. Kuypers DR Clin Pharmacol Ther; 2010 Nov; 88(5):595-6; author reply 597. PubMed ID: 20664539 [No Abstract] [Full Text] [Related]
19. Therapeutic drug monitoring of tacrolimus: a moving matter. Manzanares C Therapie; 2002; 57(2):133-6. PubMed ID: 12185961 [TBL] [Abstract][Full Text] [Related]
20. Impact of conversion to a once daily tacrolimus-based regimen in kidney transplant recipients with gastrointestinal complications. Veroux M; Grosso G; Ekser B; Corona D; Giaquinta A; Veroux P Transplantation; 2012 May; 93(9):895-9. PubMed ID: 22298033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]